natgillin/translations-raw huggingface dataset:
Preparing your nasal spray for use 
Priprava pršila za nos za uporabo
Once symptoms are controlled, dose reduction to one actuation in each nostril (total dose 100 micrograms) may be effective for maintenance. 
Ko so simptomi pod nadzorom, se odmerek lahko zmanjša na en vpih v vsako nosnico (skupni odmerek 100 mikrogramov), kar lahko zadošča za vzdrževalno zdravljenje.
if you are taking other corticosteroid medicines, either by mouth or by injection. 
• če se zdravite z drugimi kortikosteroidnimi zdravili, bodisi peroralno bodisi v obliki injekcij.
Following 12 months of treatment with NASONEX Nasal Spray in a study of patients with perennial rhinitis, there was no evidence of atrophy of the nasal mucosa; also, mometasone furoate tended to reverse the nasal mucosa closer to a normal histologic phenotype. 
Po 12-mesečnem zdravljenju z zdravilom NASONEX pršilo za nos v študiji pri bolnikih s celoletnim rinitisom ni bilo opaziti atrofije nosne sluznice, opazili so celo težnjo, da se ob uporabi mometazonfuroata nosna sluznica povrne v stanje blizu normalnega histološkega fenotipa.
• The other ingredients are dispersible cellulose, glycerol, sodium citrate, citric acid monohydrate, 
• Pomožne snovi so disperzibilna celuloza, glicerol, natrijev citrat, citronska kislina monohidrat,
When mometasone furoate is sprayed into the nose, it can help to relieve inflammation (swelling and irritation of the nose), sneezing, itching and a blocked up or runny nose. 
Po vpihu v nos mometazonfuroat pomaga lajšati vnetje (otekanje in draženje nosne sluznice), kihanje, srbenje in zamašenost ali izcedek iz nosu.
The usual dose is one spray into each nostril once daily. 
Običajni odmerek je en vpih v vsako nosnico enkrat na dan.
• 4.2 Posology and method of administration 
4.2 Odmerjanje in način uporabe
Shake container well before each use. 
Pred vsako uporabo je treba vsebnik dobro pretresti.
Nasal Polyps 
Nosna polipoza
How to use Nasonex 
Kako uporabljati zdravilo Nasonex
Each spray contains 50 micrograms of mometasone furoate, as the monohydrate. 
En vpih vsebuje 50 mikrogramov mometazonfuroata v obliki monohidrata.
If you forget to use Nasonex 
Če ste pozabili uporabiti zdravilo Nasonex
After using the spray, wipe the nozzle carefully with a clean handkerchief or tissue and replace the dust cap. 
Po uporabi nosnik previdno obrišite s čistim papirnatim ali navadnim robčkom in namestite pokrovček.
Adults (including older patients) and children 12 years of age and older: The usual recommended dose is two actuations (50 micrograms/actuation) in each nostril once daily (total dose 200 micrograms). 
Odrasli (vključno s starostniki) in otroci, stari 12 let in več: običajni priporočeni odmerek sta dva vpiha (50 mikrogramov/vpih) v vsako nosnico enkrat na dan (skupni odmerek 200 mikrogramov).
Your Nasonex Nasal Spray has a dust cap which protects the nozzle and keeps it clean. 
Nasonex pršilo za nos ima pokrovček, ki ščiti nosnik in ga ohranja čistega.
Adverse reactions are listed according to MedDRA primary system organ class. 
Neželeni učinki so razvrščeni glede na MedDRA organske sisteme.
Common side effects (may affect up to 1 in 10 people): headache sneezing nose bleeds [occurred very commonly (may affect more than1 in 10 people) in people with nasal polyps receiving Nasonex two sprays in each nostril twice a day] sore nose or throat ulcers in the nose respiratory tract infection 
• krvavitve iz nosu [zelo pogosto (pojavijo se lahko pri več kot 1 od 10 bolnikov) so se pojavile pri bolnikih z nosno polipozo, ki so prejemali dva vpiha zdravila Nasonex v vsako nosnico dvakrat dnevno]
Not known (frequency cannot be estimated from the available data): 
Pogostnost neželenih učinkov iz obdobja trženja zdravila je opredeljena kot neznana (ni mogoče ugotoviti iz razpoložljivih podatkov).
Other medicines and Nasonex Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Zdravniku ali farmacevtu povejte, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
You may also seem to develop other allergies, such as itchy, watering eyes or patches of red and itchy skin. 
Pojavijo se lahko tudi druge alergije, kot so srbenje in solzenje oči ali pordele in srbeče kožne spremembe.
If after 5 to 6 weeks symptoms are inadequately controlled, the dose may be increased to a daily dose of two sprays in each nostril twice daily (total daily dose of 400 micrograms). 
Če po 5 do 6 tednih simptomi niso zadostno nadzorovani, se dnevni odmerek lahko poveča na dva vpiha v vsako nosnico dvakrat na dan (skupni dnevni odmerek 400 mikrogramov).
How to use your nasal spray 
Kako uporabljati pršilo za nos
When used at high doses for long periods of time, corticosteroid nasal sprays may cause certain sideeffects, such as slowed growth rate in children. 
Če se kortikosteroidna pršila za nos uporablja v velikih odmerkih daljši čas, lahko povzročijo nekatere neželene učinke, kot je upočasnjena rast pri otrocih.
NASONEX Nasal Spray should not be used in the presence of untreated localised infection involving the nasal mucosa, such as herpes simplex. 
Zdravila NASONEX pršilo za nos se ne sme uporabljati pri bolnikih, ki imajo nezdravljeno lokalizirano okužbo nosne sluznice, npr. herpes simpleks.
When corticosteroid nasal sprays are used at high doses for long periods of time, side effects may occur due to the drug being absorbed in the body. 
Če se kortikosteroidna pršila za nos uporablja v velikih odmerkih daljši čas, se lahko pojavijo neželeni učinki, ki so posledica absorpcije zdravila v telo.
The usual recommended starting dose for polyposis is two actuations (50 micrograms/actuation) in each nostril once daily (total daily dose of 200 micrograms). 
Običajni priporočeni začetni odmerek za zdravljenje polipoze sta dva vpiha (50 mikrogramov/vpih) v vsako nosnico enkrat na dan (skupni dnevni odmerek 200 mikrogramov).
• [To be completed nationally] 
• [izpolni država članica]
If you stop using Nasonex 
Če ste prenehali uporabljati zdravilo Nasonex
Once symptoms are under control, your doctor may advise you to decrease your dose. 
Ko bodo simptomi pod nadzorom, vam lahko zdravnik priporoči uporabo manjšega odmerka.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON NASONEX 50 µg/actuation 60 and 140 actuations 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA NASONEX 50 µg/vpih, 60 in 140 vpihov
Perennial rhinitis occurs throughout the year and symptoms can be caused by a sensitivity to a variety of things including house dust mite, animal hair (or dander), feathers and certain foods. 
simptomi pa so lahko posledica občutljivosti na različne stvari, vključno s pršicami, živalskimi dlakami (ali prhljajem), perjem in nekaterimi živili.
If you are using the spray for the first time you need to ‘prime' the bottle by pumping the spray 10 times until a fine mist is produced: 
Pred prvo uporabo pršila ga morate “pripraviti” za uporabo tako, da 10-krat pritisnete na pršilnik, dokler iz njega ne začne pršeti fina meglica:
Table 1: 
Slika 1
If localised fungal infection of the nose or pharynx develops, discontinuance of NASONEX Nasal Spray therapy or appropriate treatment may be required. 
Če se pojavi lokalizirana glivna okužba v nosu ali žrelu, bo morda treba prekiniti zdravljenje z zdravilom NASONEX pršilo za nos ali uvesti ustrezno zdravljenje.
Systemic effects of nasal corticosteroids may occur, particularly when prescribed at high doses for prolonged periods. 
Pojavijo se lahko sistemski učinki nazalnih kortikosteroidov, predvsem pri uporabi visokih odmerkov daljše obdobje.
The European Medicines Agency has waived the obligation to submit the results of studies with NASONEX Nasal Spray and associated names in all subsets of the paediatric population in seasonal and perennial allergic rhinitis (see section 4.2 for information on paediatric use). 
Nasonex pršilo za nos za vse podskupine pediatrične populacije pri sezonskem in celoletnem alergijskem rinitisu (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
Patients receiving corticosteroids who are potentially immunosuppressed should be warned of the risk of exposure to certain infections (e.g., chickenpox, measles) and of the importance of obtaining medical advice if such exposure occurs. 
Bolnike, ki se zdravijo s kortikosteroidi in bi lahko imeli oslabljen imunski sistem, je treba opozoriti glede tveganja za izpostavljenost nekaterim okužbam (npr. noricam, ošpicam).
Epistaxis was generally self-limiting and mild in severity, and occurred at a higher incidence compared to placebo (5%), but at a comparable or lower incidence when compared to the active control nasal corticosteroids studied (up to 15%) as reported in clinical studies for allergic rhinitis. 
Krvavitev iz nosu je bila na splošno blaga in je minila sama od sebe. Kot so poročali v kliničnih študijah alergijskega rinitisa, je bila njena pojavnost večja kot pri placebu (5 %), vendar pa primerljiva ali manjša od pojavnosti pri uporabi kontrolnih nazalnih kortikosteroidov, ki so jih preučevali (do
Because the systemic bioavailability of NASONEX Nasal Spray is <1%, overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage. 
Ker je sistemska biološka uporabnost zdravila NASONEX pršilo za nos < 1 %, je v primeru prevelikega odmerjanja malo verjetno, da bo potrebno kakršno koli zdravljenje.
Inhalation or oral administration of excessive doses of corticosteroids may lead to suppression of HPA axis function. 
Inhaliranje ali peroralna uporaba prevelikih odmerkov kortikosteroidov lahko zavre delovanje osi hipotalamus-hipofiza-nadledvična žleza.
Treatment-related adverse reactions reported by system organ class and frequency Very common 
Preglednica 1: Z zdravljenjem povezani neželeni učinki, razvrščeni glede na organski sistem in pogostnost
However, patients who are transferred from long-term administration of systemically active corticosteroids to NASONEX Nasal Spray require careful attention. 
Kljub temu pa je pri bolnikih, ki so po dolgotrajnem zdravljenju s sistemsko aktivnim kortikosteroidom prešli na zdravljenje z zdravilom NASONEX pršilo za nos, potrebna posebna previdnost.
Effects noted were umbilical hernia in rats, cleft palate in mice and gallbladder agenesis, umbilical hernia, and flexed front paws in rabbits. 
Pri podganah se je pojavila umbilikalna hernija, pri miših razpoka na nebu, pri kuncih pa se ni oblikoval žolčnik, nastala je umbilikalna hernija in fleksija sprednjih tačk.
Children between the ages of 3 and 11 years: The usual recommended dose is one actuation (50 micrograms/actuation) in each nostril once daily (total dose 100 micrograms). 
Otroci, stari od 3 do 11 let: Običajni priporočeni odmerek je en vpih (50 mikrogramov/vpih) v vsako nosnico enkrat na dan (skupni odmerek 100 mikrogramov).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL NASONEX 50 µg/actuation 60 and 140 actuations 
PODATKI NA PRIMARNI OVOJNINI NALEPKA NASONEX 50 µg/vpih , 60 in 140 vpihov
Systemic corticosteroid withdrawal in such patients may result in adrenal insufficiency for a number of months until recovery of HPA axis function. 
Pri teh bolnikih lahko prekinitev uporabe sistemskega kortikosteroida povzroči nezadostno delovanje nadledvične žleze, ki lahko traja več mesecev, preden se spet vzpostavi delovanje osi hipotalamus-hipofiza-nadledvična žleza.
Following the use of intranasal corticosteroids, instances of increased intraocular pressure have been reported (see section 4.8). 
Po uporabi intranazalnih kortikosteroidov so poročali o primerih zvišanega intraokularnega tlaka
Distribution Not applicable as mometasone is poorly absorbed via the nasal route. 
Porazdelitev Navedba smiselno ni potrebna, saj se mometazon pri nazalni uporabi slabo absorbira.
At the end of the pollen season your hayfever symptoms should get better and treatment may then not be needed. 
Ob koncu sezone cvetenja bi se morali simptomi senenega nahoda izboljšati,
In the paediatric population, the incidence of recorded adverse events in clinical studies, e.g., epistaxis (6%), headache (3%), nasal irritation (2%) and sneezing (2%) was comparable to placebo. 
krvavitve iz nosu (6 %), glavobola (3 %), draženja nosne sluznice (2 %) in kihanja (2 %), primerljiva s pojavnostjo pri placebu.
Nasonex contains benzalkonium chloride which may cause nasal irritation. 
Zdravilo Nasonex vsebuje benzalkonijev klorid, ki lahko povzroči draženje nosne sluznice.
NASONEX Nasal Spray demonstrated a clinically significant onset of action within 12 hours after the first dose in some patients with seasonal allergic rhinitis; however, full benefit of treatment may not be achieved in the first 48 hours. 
NASONEX pršilo za nos pojavi v 12 urah po prvem odmerku, vendar pa polna korist zdravljenja v prvih 48 urah morda ne bo dosežena.
If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four actuations in each nostril once daily (total dose 400 micrograms). 
Če simptomi niso pod zadovoljivim nadzorom, se odmerek lahko poveča na največji dnevni odmerek, ki znaša štiri vpihe v vsako nosnico enkrat na dan (skupni odmerek 400 mikrogramov).
INFORMATION IN BRAILLE Nasonex 50 µg nasal spray [To be completed nationally] 
PODATKI V BRAILLOVI PISAVI Nasonex 50 µg pršilo za nos
There is no known information on the effect of Nasonex on the ability to drive or use machinery. 
Vpliv na sposobnost upravljanja vozil in strojev O vplivu zdravila Nasonex na sposobnost upravljanja vozil in strojev ni podatkov.
No toxicological effects unique to mometasone furoate exposure were demonstrated. 
Toksikoloških učinkov, značilnih samo za mometazonfuroat, niso dokazali.
Upper respiratory tract infection† 
Infekcijske in parazitske bolezni faringitis okužba zgornjih dihal†
What Nasonex looks like and contents of the pack Nasonex is a nasal spray suspension. 
Izgled zdravila Nasonex in vsebina pakiranja Zdravilo Nasonex je pršilo za nos v obliki suspenzije.
Epistaxis was generally self-limiting and mild in severity (see section 4.8). 
Krvavitve iz nosu so bile običajno blage in so spontano minile (glejte poglavje 4.8).
If the pump is not used for 14 days or longer, reprime the pump with 2 actuations until a uniform spray is observed, before next use. 
Če se pršilnika ne uporablja 14 dni ali več, ga je treba pred naslednjo uporabo zopet pripraviti tako, da se pršilnik sproži 2-krat, dokler pršenje ni enakomerno.
Like other glucocorticoids, mometasone furoate showed a clastogenic potential in-vitro at high concentrations. 
Tako kot drugi glukokortikoidi tudi mometazonfuroat v velikih koncentracijah in vitro deluje klastogeno.
Potential systemic effects may include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). 
Redkeje se lahko pojavijo različni psihološki ali vedenjski učinki, vključno s psihomotorično hiperaktivnostjo, motnjami spanja, anksioznostjo, depresijo ali agresivnostjo (predvsem pri otrocih).
While you are using Nasonex, talk to your doctor if your immune system is not functioning well (if you have difficulty in fighting infection) and you come into contact with anyone with measles or chickenpox. 
• če vaš imunski sistem ne deluje dobro (težavno spopadanje z okužbami) in pridete v stik z bolnikom, ki preboleva ošpice ali norice.
increase in pressure in the eye (glaucoma) and/or cataracts causing visual disturbances, damage to the partition in the nose which separates the nostrils changes in taste and smell difficulty in breathing and/or wheezing 
Pri zdravljenju s kortikosteroidnimi pršili za nos, kot je zdravilo Nasonex, je prišlo do povečanja tlaka v očesu (glavkoma) in/ali pojava sive mrene (katarakte), ki povzroči motnje vida, do poškodbe nosne pregrade, ki ločuje nosnici, in do spremembe okušanja in vonjanja.
If no improvement in symptoms is seen after 5 to 6 weeks of twice daily administration, you should contact your doctor. 
• Če se simptomi po 5 do 6 tednih uporabe zdravila dvakrat na dan ne izboljšajo, se morate posvetovati z zdravnikom.
There were also reductions in maternal body weight gains, effects on foetal growth (lower foetal body weight and/or delayed ossification) in rats, rabbits and mice, and reduced offspring survival in mice. 
Breje podgane, zajklje in miši so slabo pridobivale telesno maso, kar je vplivalo na rast ploda (manjša telesna masa plodov in/ali zapoznela okostenitev), pri miših pa se je zmanjšalo tudi število preživelih mladičev.
What is Nasonex used for? 
Za kaj uporabljamo zdravilo Nasonex?
Prime by pumping 10 times before initial use, or 2 times if unused for 14 days or more, until a fine mist is produced. 
Pred prvo uporabo 10-krat, po 14-dnevni ali daljši neuporabi pa 2-krat pritisnite na pršilnik, da iz njega začne pršeti fina meglica.
Nasonex reduces the swelling and irritation in your nose and thereby relieving sneezing, itching and a blocked-up or runny nose caused by hay fever or perennial rhinitis. 
Zdravilo Nasonex zmanjša otekanje in draženje nosne sluznice in tako olajša kihanje, srbenje in zamašenost ali izcedek iz nosu, ki so posledica senenega nahoda ali celoletnega rinitisa.
White to off-white opaque suspension. 
FARMACEVTSKA OBLIKA pršilo za nos, suspenzija bela do skoraj bela neprozorna suspenzija
What you need to know before you use Nasonex 
Kaj morate vedeti, preden boste uporabili zdravilo Nasonex Ne uporabljajte zdravila Nasonex
How to store Nasonex 
Shranjevanje zdravila Nasonex
If you have not used the spray for 14 days or more, you need to “re-prime” the bottle by pumping the spray 2 times until a fine mist is produced. 
Če pršila niste uporabljali 14 dni ali več, ga morate znova “pripraviti” za uporabo.
METHOD AND ROUTE(S) OF ADMINISTRATION For nasal use. 
POSTOPEK IN POT(I) UPORABE ZDRAVILA nazalna uporaba
Do not use Nasonex if you are allergic (hypersensitive) to mometasone furoate or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični (preobčutljivi) na mometazonfuroat ali katero koli sestavino tega zdravila
Nasonex contains benzalkonium chloride 
Zdravilo Nasonex vsebuje benzalkonijev klorid
LIST OF EXCIPIENTS Contains benzalkonium chloride 
SEZNAM POMOŽNIH SNOVI Vsebuje benzalkonijev klorid.
Also contains : dispersible cellulose, glycerol, sodium citrate, citric acid monohydrate, polysorbate 80, benzalkonium chloride, purified water. 
SEZNAM POMOŽNIH SNOVI Vsebuje tudi: disperzibilno celulozo, glicerol, natrijev citrat, citronsko kislino monohidrat, polisorbat
Push the nozzle back onto the bottle and replace the dust cap. 
• Nosnik potisnite nazaj na pršilnik in ga pokrijte s pokrovčkom.
Nasal polyps Nasonex is used to treat nasal polyps in adults aged 18 and over. 
Nosni polipi Zdravilo Nasonex uporabljamo za zdravljenje nosnih polipov pri odraslih, starih 18 let in več.
Gently shake the bottle. 
Plastenko nežno pretresite.
If your eyes are itching or irritated, your doctor may recommend that you use other treatments with Nasonex. 
Če imate težave zaradi srbenja ali draženja oči, vam lahko zdravnik poleg zdravila Nasonex priporoči še uporabo drugih zdravil.
In clinical studies, epistaxis occurred at a higher incidence compared to placebo. 
V kliničnih študijah so o krvavitvah iz nosu poročali pogosteje kot pri placebu.
NASONEX Nasal Spray is indicated for the treatment of nasal polyps in adults 18 years of age and older. 
Zdravilo NASONEX pršilo za nos je indicirano za zdravljenje nosnih polipov pri odraslih, starih 18 let in več.
Most people do not have any problems after using the nasal spray. 
Drugi neželeni učinki Večina bolnikov pri uporabi pršila za nos nima nobenih težav.
Contents of the pack and other information 
Shranjevanje zdravila Nasonex Vsebina pakiranja in dodatne informacije
It is recommended that the height of children receiving prolonged treatment with nasal corticosteroids is regularly monitored. 
Pri otrocih, ki se dolgotrajno zdravijo z nazalnimi kortikosteroidi, je priporočljivo redno nadziranje telesne višine.
There is no evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression following prolonged treatment with NASONEX Nasal Spray. 
Ni dokazov, da bi dolgotrajno zdravljenje z zdravilom NASONEX pršilo za nos supresivno delovalo na os hipotalamus-hipofiza-nadledvična žleza.
In a placebo-controlled clinical trial in which paediatric patients (n=49/group) were administered NASONEX Nasal Spray 100 micrograms daily for one year, no reduction in growth velocity was observed. 
eno leto prejemali zdravilo NASONEX pršilo za nos v odmerku 100 mikrogramov na dan, niso opazili zmanjšanja hitrosti rasti.
PHARMACEUTICAL FORM AND CONTENTS Nasal Spray Suspension 
FARMACEVTSKA OBLIKA IN VSEBINA pršilo za nos, suspenzija 60 vpihov
In 28% of the patients with seasonal allergic rhinitis, NASONEX Nasal Spray demonstrated a clinically significant onset of action within 12 hours after the first dose. 
Pri 28 % bolnikov s sezonskim alergijskim rinitisom se je klinično pomembni učinek zdravila
Treatment with NASONEX Nasal Spray may need to be initiated some days before the expected start of the pollen season in patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis. 
Pri bolnikih z anamnezo zmernih do hudih simptomov sezonskega alergijskega rinitisa je zdravljenje z zdravilom NASONEX pršilo za nos morda treba uvesti nekaj dni pred pričakovanim začetkom sezone cvetnega prahu.
This medicinal product is authorised in the Member States of the EEA under the following names: [See Annex I - To be completed nationally] 
[glejte Prilogo I - izpolni država članica] Zdravilo je v državah članicah EGP pridobilo dovoljenje za promet z naslednjimi imeni:
The usual dose is two sprays into each nostril once a day. 
Največji dnevni odmerek so štirje vpihi v vsako nosnico enkrat na dan.
In a study involving 48 children aged 3 to 5 years treated with intranasal mometasone furoate 50, 100 or 200 µg/day for 14 days, there was no significant differences from placebo in the mean change in plasma cortisol level in response to the tetracosactrin stimulation test. 
200 µg/dan, se povprečna sprememba vrednosti kortizola v plazmi po stimulacijskem testu s tetrakozaktidom ni pomembneje razlikovala od placeba.
Nasal Spray, Suspension. 
- Navodilo shranite.
(Figure 2) Tilt your head forward slightly, keeping the bottle upright. 
Glavo rahlo nagnite naprej, plastenka pa naj ostane v pokončnem položaju.
Shake the bottle gently and remove the dust cap. (Figure 1) Gently blow your nose. 
Plastenko rahlo pretresite in snemite pokrovček (slika 1).
Increased intraocular pressure 
Očesne bolezni glavkom zvišan intraokularni tlak katarakte
[See Annex I - To be completed nationally] {Name and Address} <{tel}> <{fax}> <{e-mail}> 
{Ime in naslov} <{tel.}> <{faks}> <{e-pošta}>
Mometasone furoate, administered as an aqueous nasal spray, has a systemic bioavailability of <1% in plasma, using a sensitive assay with a lower quantitation limit of 0.25 pg/ml. 
določena z uporabo občutljivega testa s spodnjo mejo kvantivikacije 0,25 pg/ml.
NASONEX Nasal Spray contains benzalkonium chloride which may cause nasal irritation. 
Zdravilo NASONEX pršilo za nos vsebuje benzalkonijev klorid, ki lahko draži nosno sluznico.
The spray will need to be primed again with 2 sprays when first used after cleaning. 
• Pri prvi uporabi pršilnika po čiščenju morate pršilnik z 2 pršenjema znova pripraviti za uporabo.
Keep this leaflet. 
Nosnika ne predirajte.
NASONEX Nasal Spray should be used with caution, if at all, in patients with active or quiescent tuberculous infections of the respiratory tract, or in untreated fungal, bacterial, or systemic viral infections. 
Pri bolnikih, ki imajo aktivno ali latentno tuberkulozo dihal, nezdravljeno glivno, bakterijsko ali sistemsko virusno okužbo, je treba zdravilo NASONEX pršilo za nos previdno uporabljati, če je uporaba sploh primerna.